NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
NASDAQ:NLSP
Price:
0.762
USD
2.97%
Market Closed
Market Cap:
$4.6m
Balance Sheet
Balance Sheet Decomposition
NLS Pharmaceutics AG
NLS Pharmaceutics AG
Balance Sheet Decomposition is not available for
NLS Pharmaceutics AG
NLS Pharmaceutics AG
Balance Sheet
NLS Pharmaceutics AG
NLS Pharmaceutics AG
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
0
|
0
|
0
|
5
|
9
|
1
|
2
|
|
| Cash Equivalents |
2
|
0
|
0
|
0
|
5
|
9
|
1
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
2
|
0
|
0
|
0
|
6
|
9
|
2
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
0
-93%
|
1
+367%
|
1
+73%
|
6
+376%
|
9
+61%
|
2
-80%
|
2
+21%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
3
|
4
|
2
|
2
|
5
|
1
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
0
|
|
| Short-Term Debt |
0
|
1
|
1
|
1
|
0
|
0
|
2
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
4
|
7
|
2
|
3
|
8
|
1
|
|
| Long-Term Debt |
9
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
|
| Total Liabilities |
10
N/A
|
9
-10%
|
7
-23%
|
10
+48%
|
5
-49%
|
6
+15%
|
11
+78%
|
1
-92%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
|
| Retained Earnings |
16
|
21
|
27
|
30
|
42
|
58
|
70
|
74
|
|
| Additional Paid In Capital |
8
|
13
|
21
|
21
|
42
|
61
|
61
|
73
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
9
-14%
|
6
+30%
|
9
-46%
|
1
N/A
|
3
+507%
|
9
N/A
|
1
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
0
-93%
|
1
+367%
|
1
+73%
|
6
+376%
|
9
+61%
|
2
-80%
|
2
+21%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
12
|
16
|
32
|
1
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
